Style | Citing Format |
---|---|
MLA | Tarighatnia A, et al.. "Current Challenges and New Opportunities of Hybrid Nanoparticles for Diagnosis and Treatment of Cancer." Frontiers in Biomedical Technologies, vol. 11, no. 1, 2024, pp. 1-5. |
APA | Tarighatnia A, Mahmoudi G, Kiani M, Nader ND (2024). Current Challenges and New Opportunities of Hybrid Nanoparticles for Diagnosis and Treatment of Cancer. Frontiers in Biomedical Technologies, 11(1), 1-5. |
Chicago | Tarighatnia A, Mahmoudi G, Kiani M, Nader ND. "Current Challenges and New Opportunities of Hybrid Nanoparticles for Diagnosis and Treatment of Cancer." Frontiers in Biomedical Technologies 11, no. 1 (2024): 1-5. |
Harvard | Tarighatnia A et al. (2024) 'Current Challenges and New Opportunities of Hybrid Nanoparticles for Diagnosis and Treatment of Cancer', Frontiers in Biomedical Technologies, 11(1), pp. 1-5. |
Vancouver | Tarighatnia A, Mahmoudi G, Kiani M, Nader ND. Current Challenges and New Opportunities of Hybrid Nanoparticles for Diagnosis and Treatment of Cancer. Frontiers in Biomedical Technologies. 2024;11(1):1-5. |
BibTex | @article{ author = {Tarighatnia A and Mahmoudi G and Kiani M and Nader ND}, title = {Current Challenges and New Opportunities of Hybrid Nanoparticles for Diagnosis and Treatment of Cancer}, journal = {Frontiers in Biomedical Technologies}, volume = {11}, number = {1}, pages = {1-5}, year = {2024} } |
RIS | TY - JOUR AU - Tarighatnia A AU - Mahmoudi G AU - Kiani M AU - Nader ND TI - Current Challenges and New Opportunities of Hybrid Nanoparticles for Diagnosis and Treatment of Cancer JO - Frontiers in Biomedical Technologies VL - 11 IS - 1 SP - 1 EP - 5 PY - 2024 ER - |